EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells



Resistance to apoptosis is correlated with the reduced caspase-3 activation and enhanced expression of antiapoptotic proteins in human cervical multidrug-resistant cells



Biochemical and Biophysical Research Communications 270(2): 415-420



Recent studies have indicated that induction of apoptosis is the primary cytotoxic mechanism of most cancer chemotherapeutic agents, and abnormalities in the control of apoptosis can affect the sensitivity of malignant cells to multiple drugs. Here, we treated cells with cisplatin and other apoptotic stimuli and found that multidrug-resistant (MDR) endocervical HEN-16-2/CDDP cells, compared with drug-sensitive parental cells, were significantly more resistant to apoptosis and exhibited decreased proteolytic activation of caspase-3. The latter was further demonstrated by decreased cleavage of its substrate poly(ADP-ribose) polymerase (PARP). Further, Western blot analysis showed that MDR HEN-16-2/CDDP cells had significantly higher levels of the apoptosis-inhibiting proteins BAG-1 p50 and p33 isoforms and Bcl-X(L). This study provided the first evidence that overexpression of antiapoptotic BAG-1 p50 and p33 and Bcl-X(L) may cause resistance to apoptosis through reduction of caspase-3 activity in human cervical cells having an MDR phenotype.

(PDF emailed within 0-6 h: $19.90)

Accession: 011289810

Download citation: RISBibTeXText

PMID: 10753639

DOI: 10.1006/bbrc.2000.2432



Related references

Multidrug resistance in human cervical cells is associated with enhanced expression of anti-apoptotic proteins BAG-1 and Bcl-XL and reduced caspase-3 activity. Proceedings of the American Association for Cancer Research Annual Meeting (41): 404, March, 2000

Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line. Journal of Biological Chemistry 281(27): 18401-7, 2006

Enhanced expression of multidrug resistance-associated protein 2 and reduced expression of aquaglyceroporin 3 in an arsenic-resistant human cell line (vol 281, pg 18403, 2006). Journal of Biological Chemistry 282(15): 11612, 2007

Resistance to diverse apoptotic triggers in multidrug resistant HL60 cells and its possible relationship to the expression of P-glycoprotein, Fas and of the novel anti-apoptosis factors IAP (inhibitory of apoptosis proteins). Cancer Letters 180(1): 91-101, 2002

Metal-catalyzed oxidation of extracellular matrix proteins promotes human mesangial cell apoptosis and is associated with enhanced expression of Bax and caspase activation. Biochemical and Biophysical Research Communications 292(3): 652-658, 2002

Enhanced expression of the multidrug resistance gene in vindesine-resistant human esophageal cancer cells. Oncology 51(5): 440-445, 1994

The novel Akt inhibitor, perifosine, induces caspase-dependent apoptosis and downregulates P-glycoprotein expression in multidrug-resistant human T-acute leukemia cells by a JNK-dependent mechanism. Leukemia (Basingstoke) 22(6): 1106-1116, 2008

Curcumin induces caspase-3-independent apoptosis in human multidrug-resistant cells. Annals of the New York Academy of Sciences 973: 250-254, 2002

Fisetin induces apoptosis in human cervical cancer HeLa cells through ERK1/2-mediated activation of caspase-8-/caspase-3-dependent pathway. Archives of Toxicology 86(2): 263-273, 2012

Flavopiridol suppresses tumor necrosis factor-induced activation of activator protein-1, c-Jun N-terminal kinase, p38 mitogen-activated protein kinase (MAPK), p44/p42 MAPK, and Akt, inhibits expression of antiapoptotic gene products, and enhances apoptosis through cytochrome c release and caspase activation in human myeloid cells. Molecular Pharmacology 73(5): 1549-1557, 2008

Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells. Leukemia Research 31(7): 989-994, 2006

Cytochrome c release is upstream to activation of caspase-9, caspase-8, and caspase-3 in the enhanced apoptosis of anaplastic thyroid cancer cells induced by manumycin and paclitaxel. Journal of Clinical Endocrinology and Metabolism 86(10): 4731-4740, 2001

Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer. Journal of Cancer Research and Clinical Oncology 130(7): 423-428, 2004

Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF‑κB/COX‑2‑caspase-1 pathway in HeLa cervical cancer cells. International Journal of Oncology 45(5): 1929-1936, 2015

Inhibition of multidrug resistance-associated protein expression in neuroblastoma cells induces spontaneous differentiation, apoptosis and reduced Bcl-2 expression. Proceedings of the American Association for Cancer Research Annual Meeting 40: 224, March, 1999